Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Cash and Short Term Investments (Quarterly): 14.85M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.85M |
| September 30, 2023 | 20.70M |
| June 30, 2023 | 17.47M |
| March 31, 2023 | 18.47M |
| December 31, 2022 | 22.86M |
| September 30, 2022 | 17.40M |
| June 30, 2022 | 21.51M |
| March 31, 2022 | 26.72M |
| December 31, 2021 | 19.46M |
| September 30, 2021 | 13.50M |
| June 30, 2021 | 27.18M |
| March 31, 2021 | 24.91M |
| December 31, 2020 | 28.37M |
| September 30, 2020 | 22.86M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.19M |
| March 31, 2020 | 13.66M |
| December 31, 2019 | 14.15M |
| September 30, 2019 | 18.30M |
| June 30, 2019 | 9.240M |
| March 31, 2019 | 14.32M |
| December 31, 2018 | 19.73M |
| September 30, 2018 | 21.04M |
| June 30, 2018 | 24.56M |
| March 31, 2018 | 27.60M |
| December 31, 2017 | 5.250M |
| September 30, 2017 | 7.406M |
| December 31, 2016 | 3.387M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
9.240M
Minimum
Jun 2019
28.37M
Maximum
Dec 2020
19.04M
Average
18.47M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.13M |
| Alpine Immune Sciences Inc | 327.41M |
| Lantern Pharma Inc | 41.30M |
| Oragenics Inc | 3.484M |
| MAIA Biotechnology Inc | 7.151M |